The Economics of an HIV/AIDS Vaccine

54 Pages Posted: 29 Oct 2014 Last revised: 30 Jun 2015

Date Written: October 28, 2014

Abstract

We survey the main economic aspects of the creation of an AIDS vaccine. We first describe the market conditions for this vaccine, and we show the critical importance of patents to start the costly R&D process. We then describe the main economic impediments to this venture, and the main financial mechanisms in place to alleviate them. We pinpoint their pitfalls, and we finally present novel mechanisms capable of restoring economic efficiency, and of providing greater incentives for investors to undertake R&D in this vaccine.

Keywords: HIV/Aids vaccine, R&D incentives, financial mechanisms, health underinvestment, patent protection

JEL Classification: I01, I03, G15

Suggested Citation

Leoni, Patrick L., The Economics of an HIV/AIDS Vaccine (October 28, 2014). Available at SSRN: https://ssrn.com/abstract=2515834 or http://dx.doi.org/10.2139/ssrn.2515834

Patrick L. Leoni (Contact Author)

Kedge Business School ( email )

Domaine de Luminy - BP 921
BP 921
Marseille, PACA 13288
France

Register to save articles to
your library

Register

Paper statistics

Downloads
66
Abstract Views
423
rank
335,477
PlumX Metrics